RNA-seq data and mechanistic studies of monocytes verified that PTBP2-treated NB cells shaped monocytes/Mφs to a classical phenotype by activating the IFN-I pathway, which had no obvious correlation with the CCL5/CCR5 axis. The gene discussed is CCL5; the disease is neuroblastoma.